Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online October 31, 2007
Diabetes 57:279-287, 2008
DOI: 10.2337/db07-0520
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0520v1
57/2/279    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Weksler-Zangen, S.
Right arrow Articles by Kaiser, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weksler-Zangen, S.
Right arrow Articles by Kaiser, N.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Impaired Glucose-Stimulated Insulin Secretion Is Coupled With Exocrine Pancreatic Lesions in the Cohen Diabetic Rat

Sarah Weksler-Zangen1, Itamar Raz1, Sigurd Lenzen2, Anne Jörns3, Shira Ehrenfeld1, Gail Amir4, Andrei Oprescu5, Yoram Yagil6, Chana Yagil6, David H. Zangen7, and Nurit Kaiser5

1 The Diabetes Unit, Department of Internal Medicine and The Hadassah Diabetes Center, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
2 Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany
3 Centre of Anatomy, Hannover Medical School, Hannover, Germany
4 Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
5 Endocrinology and Metabolism Service, Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
6 Laboratory for Molecular Medicine and Israeli Rat Genome Center, Faculty of Health Sciences, Barzilai Medical Center, Campus of the Ben-Gurion University, Ashkelon, Israel
7 Division of Pediatric Endocrinology, Department of Pediatrics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Address correspondence and reprint requests to Sarah Weksler-Zangen, The Diabetes Unit, Hadassah-Hebrew University Medical Center, Jerusalem 1200, Israel 91120. E-mail: sarahz{at}hadassah.org.il

Abbreviations: AUC, area under the curve; BrdU, 5-bromo-2'-deoxyuridine; CDr-HSD, Cohen diabetes–resistant rats fed high-sucrose, copper-poor diet; CDs-HSD, Cohen diabetes–sensitive rats fed high-sucrose, copper-poor diet; FFA, free fatty acid; GSIS, glucose-stimulated insulin secretion; IL, interleukin; iNOS, inducible nitric oxide synthase; ITT, insulin tolerance test; IVGTT, intravenous glucose tolerance test; KRBB, Krebs-Ringer bicarbonate buffer; KRBH-BSA, modified KRBB containing 20 mmol/l HEPES and 0.25% BSA; OGTT, oral glucose tolerance test; RIA, radioimmunoassay; SEM, scanning electron microscopy; TG, triglyceride; TUNEL, terminal dUTP 3' nick end-labeling

OBJECTIVE—The Cohen diabetes–sensitive rat develops postprandial hyperglycemia when fed a high-sucrose, copper-poor diet, whereas the Cohen diabetes–resistant rat maintains normoglycemia. The pathophysiological basis of diabetes was studied in the Cohen diabetic rat centering on the interplay between the exocrine and endocrine compartments of the pancreas.

RESEARCH DESIGN AND METHODS—Studies used male Cohen diabetes–sensitive and Cohen diabetes–resistant rats fed 1-month high-sucrose, copper-poor diet. Serum insulin and glucose levels were measured during glucose and insulin tolerance tests. The pancreas was evaluated for weight, insulin content, macrophage, and fat infiltration. Glucose-stimulated insulin secretion (GSIS) was determined in isolated perfused pancreas and in islets.

RESULTS—Hyperglycemic Cohen diabetes–sensitive rats exhibited reduced pancreatic weight with lipid deposits and interleukin-1β–positive macrophage infiltration in the exocrine pancreas. Islet morphology was preserved, and total pancreatic insulin content did not differ from that of Cohen diabetes–resistant rats. Lipids did not accumulate in skeletal muscle, nor was insulin resistance observed in hyperglycemic Cohen diabetes–sensitive rats. Intravenous glucose-tolerance test revealed markedly elevated glucose levels associated with diminished insulin output. Insulin release was induced in vivo by the non-nutrient secretagogues arginine and tolbutamide, suggesting a selective unresponsiveness to glucose. Decreased GSIS was observed in the isolated perfused pancreas of the hyperglycemic Cohen diabetes–sensitive rat, whereas islets isolated from these rats exhibited glucose-dependent insulin secretion and proinsulin biosynthesis.

CONCLUSIONS—The association of the in vivo insulin secretory defect with lipid accumulation and activated macrophage infiltration in the exocrine pancreas suggests that changes in the islet microenvironment are the culprit in the insulin secretory malfunction observed in vivo.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.